Revogen Biologics

RevoGen Biologics is dedicated to enhancing patient outcomes by developing and distributing advanced biologic products and diagnostics. The company focuses on delivering high-quality, innovative biologics to physicians, surgeons, and patients, emphasizing client-centric service and rigorous quality standards. Specializing in tissue-derived biologics, RevoGen offers a diverse product portfolio that includes surgical allografts, amnion patches, surgical synthetics, and soft-tissue allografts. Their products cater to various medical specialties, such as spine and neurology, sports medicine, wound care, orthopedics, cosmetic surgery, colorectal, OB/Gyn, podiatry, and ocular care. Notable offerings include ocular grafts for ocular diseases, RevoShield+® patches for wound treatment, and a range of surgical grafts for various applications. RevoGen Biologics prioritizes safety and efficacy through stringent donor screening and established guidelines. The company values its distribution partners, supporting them to enhance service delivery and strengthen relationships with healthcare providers. Overall, RevoGen is committed to improving patient lives through innovative biologic solutions and strong partnerships.

• Employees 11